Home  >  Products  >  ARFGAP3 (ADP-ribosylation factor GTPase activating protein 3 ) Blocking Peptide (the C terminal of ARFGAP3)(100ug)
ARFGAP3 (ADP-ribosylation factor GTPase activating protein 3 ) Blocking Peptide (the C terminal of ARFGAP3)(100ug)

ARFGAP3 (ADP-ribosylation factor GTPase activating protein 3 ) Blocking Peptide (the C terminal of ARFGAP3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ARFGAP3 Antibody (ARP61868_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61868
Size: 100ug
Weight: 57kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The protein encoded by this gene is a GTPase-activating protein (GAP) that associates with the Golgi apparatus and regulates the early secretory pathway of proteins. The encoded protein promotes hydrolysis of ADP-ribosylation factor 1 (ARF1)-bound GTP, which is required for the dissociation of coat proteins from Golgi-derived membranes and vesicles. Dissociation of the coat proteins is a prerequisite for the fusion of these vesicles with target compartments. The activity of this protein is sensitive to phospholipids. Multiple transcript variants encoding different isoforms have been found for this gene. This gene was originally known as ARFGAP1, but that is now the name of a related but different gene.
Alternative names: ARFGAP1; FLJ45618
See Full Product Listings >